What is Insight Molecular Diagnostics Inc. Common Stock's Enterprise Value?

Insight Molecular Diagnostics Inc. Common Stock's Enterprise Value is $122.0M, based on as-reported figures from SEC (XBRL) filings.

What is Insight Molecular Diagnostics Inc. Common Stock's Price / Sales?

Insight Molecular Diagnostics Inc. Common Stock's Price / Sales is 83.7×, based on as-reported figures from SEC (XBRL) filings.

What is Insight Molecular Diagnostics Inc. Common Stock's Revenue (TTM)?

Insight Molecular Diagnostics Inc. Common Stock's Revenue (TTM) is $1.7M, based on as-reported figures from SEC (XBRL) filings.

What is Insight Molecular Diagnostics Inc. Common Stock's Net Income (TTM)?

Insight Molecular Diagnostics Inc. Common Stock's Net Income (TTM) is -$49.4M, based on as-reported figures from SEC (XBRL) filings.

What is Insight Molecular Diagnostics Inc. Common Stock's Diluted EPS (TTM)?

Insight Molecular Diagnostics Inc. Common Stock's Diluted EPS (TTM) is -1.51, based on as-reported figures from SEC (XBRL) filings.

What is Insight Molecular Diagnostics Inc. Common Stock's EBITDA Margin?

Insight Molecular Diagnostics Inc. Common Stock's EBITDA Margin is -2865.6%, based on as-reported figures from SEC (XBRL) filings.

Insight Molecular Diagnostics Inc. Common Stock (IMDX) Financial Statements

Insight Molecular Diagnostics Inc. Common Stock

SIC 2835 · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

FIGI BBG008P5VFW0

XNAS · usd

4.27▲ 0.14 (3.39%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close4.13

Day's Range3.85 – 4.32

52-Week Range2.40 – 8.51

Volume212.8K

Avg Volume188.3K

Share Statistics

Shares Outstanding

Employees58

ExchangeXNAS

Listed2015-12-30

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Insight Molecular Diagnostics Inc. Common Stock (IMDX)

What is Insight Molecular Diagnostics Inc. Common Stock's Market Cap?: Insight Molecular Diagnostics Inc. Common Stock's Market Cap is $139.7M, based on as-reported figures from SEC (XBRL) filings.
What is Insight Molecular Diagnostics Inc. Common Stock's Enterprise Value?: Insight Molecular Diagnostics Inc. Common Stock's Enterprise Value is $122.0M, based on as-reported figures from SEC (XBRL) filings.
What is Insight Molecular Diagnostics Inc. Common Stock's Price / Sales?: Insight Molecular Diagnostics Inc. Common Stock's Price / Sales is 83.7×, based on as-reported figures from SEC (XBRL) filings.
What is Insight Molecular Diagnostics Inc. Common Stock's EV / Revenue?: Insight Molecular Diagnostics Inc. Common Stock's EV / Revenue is 73.0×, based on as-reported figures from SEC (XBRL) filings.
What is Insight Molecular Diagnostics Inc. Common Stock's EV / EBITDA?: Insight Molecular Diagnostics Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Insight Molecular Diagnostics Inc. Common Stock's Revenue (TTM)?: Insight Molecular Diagnostics Inc. Common Stock's Revenue (TTM) is $1.7M, based on as-reported figures from SEC (XBRL) filings.
What is Insight Molecular Diagnostics Inc. Common Stock's Net Income (TTM)?: Insight Molecular Diagnostics Inc. Common Stock's Net Income (TTM) is -$49.4M, based on as-reported figures from SEC (XBRL) filings.
What is Insight Molecular Diagnostics Inc. Common Stock's EBITDA?: Insight Molecular Diagnostics Inc. Common Stock's EBITDA is -$47.9M, based on as-reported figures from SEC (XBRL) filings.
What is Insight Molecular Diagnostics Inc. Common Stock's Diluted EPS (TTM)?: Insight Molecular Diagnostics Inc. Common Stock's Diluted EPS (TTM) is -1.51, based on as-reported figures from SEC (XBRL) filings.
What is Insight Molecular Diagnostics Inc. Common Stock's EBITDA Margin?: Insight Molecular Diagnostics Inc. Common Stock's EBITDA Margin is -2865.6%, based on as-reported figures from SEC (XBRL) filings.